Woiwode Thomas Insider Trades

Insider Trading History

Track insider trading activity for Woiwode Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Passage Bio
Passage Bio PASG
10% owner
Holding Value $143k 24,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$480k 24,000 shares
$20.00
$5.97
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $77.1k 15,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$503k 15,000 shares
$33.50
$5.14
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $4.45k 3,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.28k 3,500 shares
$2.08
$1.27
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $3.71k 3,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.71k 3,500 shares
$1.06
$1.06
Passage Bio
Passage Bio PASG
Director
Holding Value $143k 24,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$845k 24,000 shares
$35.20
$5.97
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $2.69M 2,118,644 shares
Last Trade
Apr 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.65M 2,118,644 shares
$3.61
$1.27
Millendo Therapeutics
Millendo Therapeutics MLND
10% owner
Holding Value $2.25M 2,118,644 shares
Last Trade
Apr 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.25M 2,118,644 shares
$1.06
$1.06
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $7.03k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.03k 6,635 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $8.43k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 6,635 shares
$11.07
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $8.43k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 6,635 shares
$11.07
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $1.49M 1,171,094 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.6M 2,176,411 shares
$15.90
$1.27
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $77.1k 15,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.97M 15,000 shares
$664.50
$5.14
Passage Bio
Passage Bio PASG
10% owner
Holding Value $101k 16,918 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.68M 16,918 shares
$276.60
$5.97
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $174k 40,000 shares
Last Trade
May 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 40,000 shares
$3.70
$4.36
Gritstone Bio
Gritstone Bio GRTS
Director
Holding Value $43.4k 1,347,709 shares
Last Trade
Dec 30, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 1,347,709 shares
$3.71
$0.03
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $82.1k 18,822 shares
Last Trade
Dec 14, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$179k 12,783 shares
$14.01
$4.36
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $4.43M 862,444 shares
Last Trade
Oct 20, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$66M 200,000 shares
$330.00
$5.14
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $131k 30,000 shares
Last Trade
Jun 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$769k 30,000 shares
$25.64
$4.36
Gritstone Bio
Gritstone Bio GRTS
10% owner
Holding Value $403 12,500 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.3k 12,500 shares
$6.66
$0.03
Passage Bio
Passage Bio PASG
10% owner
Holding Value $5.57M 933,352 shares
Last Trade
Mar 03, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90M 225,000 shares
$400.00
$5.97

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up